Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia
- PMID: 8471425
- PMCID: PMC1968351
- DOI: 10.1038/bjc.1993.126
Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia
Abstract
The effects of progressive cachexia on protein metabolism in skeletal muscle has been investigated in mice bearing the MAC16 adenocarcinoma which produces cachexia with tumour burdens of < 1% of the host weight. Weight loss was accompanied by loss of whole body nitrogen in proportion to the overall loss of body mass. Using L-[4-3H]phenylalanine to label proteins in gastrocnemius muscle, a significant depression (60%) in protein synthesis occurred in animals with a weight loss between 15 and 30% accompanied by an increase in protein degradation, which increased with increasing weight loss between 15 and 30%. Muscle degradation in vitro could be achieved by serum from cachectic animals, which appeared to contain a proteolysis-inducing factor. These results suggest that the increased degradation of skeletal muscle seen in this model of cachexia may be due to a circulating proteolysis-inducing factor.
Similar articles
-
Mechanism of muscle protein degradation in cancer cachexia.Br J Cancer. 1993 Aug;68(2):314-8. doi: 10.1038/bjc.1993.334. Br J Cancer. 1993. PMID: 8347486 Free PMC article.
-
Induction of muscle protein degradation by a tumour factor.Br J Cancer. 1997;76(8):1035-40. doi: 10.1038/bjc.1997.504. Br J Cancer. 1997. PMID: 9376263 Free PMC article.
-
Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia.Anticancer Res. 2006 Nov-Dec;26(6B):4149-54. Anticancer Res. 2006. PMID: 17201126
-
Loss of skeletal muscle in cancer: biochemical mechanisms.Front Biosci. 2001 Feb 1;6:D164-74. doi: 10.2741/tisdale. Front Biosci. 2001. PMID: 11171557 Review.
-
Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.Histol Histopathol. 2007 Jul;22(7):805-14. doi: 10.14670/HH-22.805. Histol Histopathol. 2007. PMID: 17455154 Review.
Cited by
-
Variable body and tissue weight reporting in preclinical cachexia literature may alter study outcomes and interpretation.Dis Model Mech. 2023 Jul 1;16(7):dmm050148. doi: 10.1242/dmm.050148. Epub 2023 Jul 18. Dis Model Mech. 2023. PMID: 37350419 Free PMC article.
-
Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies.J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1150-1167. doi: 10.1002/jcsm.13073. Epub 2023 Mar 2. J Cachexia Sarcopenia Muscle. 2023. PMID: 36864755 Free PMC article. Review.
-
Prevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions.Int J Mol Sci. 2023 Feb 3;24(3):2973. doi: 10.3390/ijms24032973. Int J Mol Sci. 2023. PMID: 36769296 Free PMC article. Review.
-
The Contribution of Tumor Derived Exosomes to Cancer Cachexia.Cells. 2023 Jan 12;12(2):292. doi: 10.3390/cells12020292. Cells. 2023. PMID: 36672227 Free PMC article. Review.
-
Cancer cachexia: Pathophysiology and association with cancer-related pain.Front Pain Res (Lausanne). 2022 Aug 22;3:971295. doi: 10.3389/fpain.2022.971295. eCollection 2022. Front Pain Res (Lausanne). 2022. PMID: 36072367 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
